郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

病毒感染Design of novel and highly selective SARS-CoV-2 main protease inhibitors.

期刊：Antimicrobial agents and chemotherapy发表年份：2024作者：Adi N R Poli; Ian Tietjen; Nitesh K Nandwana; Joel Cassel; Troy E Messick; Emery T Register; Frederick Keeney; Rajesh Rajaiah; Atul K Verma; Kabita Pandey; Arpan Acharya; Siddappa N Byrareddy; Luis J Montaner; Joseph M Salvino
阅读更多 →

病毒感染An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo.

期刊：Cell reports发表年份：2024作者：Nian E Zhou; Su Tang; Xuelin Bian; Maloy K Parai; Inna V Krieger; Armando Flores; Pradeep K Jaiswal; Radha Bam; Jeremy L Wood; Zhe Shi; Laura J Stevens; Trevor Scobey; Meghan V Diefenbacher; Fernando R Moreira; Thomas J Baric; Arjun Acharya; Joonyoun
阅读更多 →

病毒感染Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.

期刊：Nature communications发表年份：2021作者：Malina A Bakowski; Nathan Beutler; Karen C Wolff; Melanie G Kirkpatrick; Emily Chen; Tu-Trinh H Nguyen; Laura Riva; Namir Shaabani; Mara Parren; James Ricketts; Anil K Gupta; Kastin Pan; Peiting Kuo; MacKenzie Fuller; Elijah Garcia; John R Teijaro; L
阅读更多 →

病毒感染Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19.

期刊：Nature communications发表年份：2021作者：Geraldine Nouailles; Emanuel Wyler; Peter Pennitz; Dylan Postmus; Daria Vladimirova; Julia Kazmierski; Fabian Pott; Kristina Dietert; Michael Muelleder; Vadim Farztdinov; Benedikt Obermayer; Sandra-Maria Wienhold; Sandro Andreotti; Thomas Hoefler; Bi
阅读更多 →